Walker's Research Business Information
A publisher of Business Information since 1983  
  
 
Search Business Search Executive   Advanced Search
 
Sign In  |  Hints

Profile of Frank Bulens
 

Frank Bulens

 
Board Dir. - Ceres Inc.
 
Frank Bulens Email :
Please login
 
Company Name : Ceres Inc.
 
Company Website : www.ceres-inc.com
 
Company Address : 1535 Rancho Conejo Blvd.
, Thousand Oaks, CA,
United States,
 
Frank Bulens Profile :
Board Dir. - Ceres Inc.
 
Frank Bulens Biography :

Dr. Bulens is the Executive Investment Manager in the Department Venture Capital – Life Science at GIMV N.V., a Flemish investment company that is a shareholder of Ceres. Current board positions include: Ablynx in Belgium, Innate Pharma and Diatos in France. Dr. Bulens has also been or is still involved with other investments like CareX in France, Inpharmatica and Arrow Therapeutics in the UK as well as Nereus Pharmaceuticals, Aclara Biosciences, X-Ceptor and Memory Pharmaceuticals in the U.S. Previously, Dr. Bulens was a senior scientific advisor with IWT, a Flemish governmental research fund organization and held a research position in the food industry. He holds an engineering degree in Chemistry/Biochemistry and was a scientific staff member of the Centre for Molecular and Vascular Biology, Faculty of Medicine, University of Leuven, where he obtained a MSci. and Ph.D. in Medical Sciences. Dr. Bulens has served as a director of Ceres since July 2002.

 
Frank Bulens Colleagues :
Name Title Email

Richard Hamilton

Pres., CEO, Board Dir. Please login

Richard Flavell

Chief Scientific Officer Please login

Wilfriede Van Assche

Sr. VP Please login

Kenneth Feldmann

VP - Agricultural Genomics, Trait Development Please login

Peter Mascia

VP - Product Development Please login


            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory   
 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.